[{"address1": "Ole MaalOees Vej 3", "address2": "Copenhagen N", "city": "Copenhagen", "zip": "2200", "country": "Denmark", "phone": "45 70 70 29 80", "website": "https://www.iobiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead therapeutic cancer vaccine candidate includes IO102-IO103, which targets cancer cells and immune-suppressive cells in the tumor microenvironment that express indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide to target T cells that recognize epitopes derived from Arginase 1, which is an immunoregulatory enzyme highly expressed in difficult-to-treat tumors associated with high levels of myeloid-derived suppressor cells, including renal cell carcinoma, head and neck, breast, pancreatic, ovarian, colorectal, and prostate cancers. In addition, the company develops IO170, a TGF\u00df1 vaccine for the treatment of solid tumors. IO Biotech, Inc. was incorporated in 2014 and is based in Copenhagen, Denmark.", "fullTimeEmployees": 80, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mai-Britt  Zocca Ph.D.", "age": 57, "title": "Founder, President, CEO, Principal Financial Officer & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 908461, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Amy B. Sullivan M.B.A.", "age": 55, "title": "Principal Accounting Officer & CFO", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 650708, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Qasim Iftikhar Ahmad M.D.", "age": 54, "title": "Chief Medical Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 709800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Inge Marie Svane M.D., Ph.D.", "title": "Founder & Clinical Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Mads Hald Andersen M.D., Ph.D.", "title": "Co-Founder & Scientific Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Anders  Ljungqvist", "title": "Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Per Thor Straten", "title": "Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Faulkner M.B.A.", "title": "Chief Technical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Devin Whittemore Smith J.D.", "age": 57, "title": "Secretary, General Counsel & Chief Compliance Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 621800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel G. Mannix Ph.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.561, "open": 0.56, "dayLow": 0.56, "dayHigh": 0.59, "regularMarketPreviousClose": 0.561, "regularMarketOpen": 0.56, "regularMarketDayLow": 0.56, "regularMarketDayHigh": 0.59, "payoutRatio": 0.0, "beta": 0.498, "forwardPE": -1.5622221, "volume": 531407, "regularMarketVolume": 531407, "averageVolume": 2464878, "averageVolume10days": 746300, "averageDailyVolume10Day": 746300, "bid": 0.59, "ask": 0.8265, "bidSize": 1, "askSize": 2, "marketCap": 40464028, "fiftyTwoWeekLow": 0.323, "fiftyTwoWeekHigh": 2.79, "allTimeHigh": 17.88, "allTimeLow": 0.323, "fiftyDayAverage": 0.7519, "twoHundredDayAverage": 1.188895, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 27919028, "profitMargins": 0.0, "floatShares": 43401700, "sharesOutstanding": 71948842, "sharesShort": 2015986, "sharesShortPriorMonth": 2426960, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.027999999, "heldPercentInsiders": 0.05145, "heldPercentInstitutions": 0.48106998, "shortRatio": 2.26, "shortPercentOfFloat": 0.0535, "impliedSharesOutstanding": 71948842, "bookValue": 0.013, "priceToBook": 43.261536, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -88349000, "trailingEps": -1.34, "forwardEps": -0.36, "enterpriseToEbitda": -0.304, "52WeekChange": -0.3499421, "SandP52WeekChange": 0.18594909, "quoteType": "EQUITY", "currentPrice": 0.5624, "targetHighPrice": 4.0, "targetLowPrice": 0.36, "targetMeanPrice": 2.45333, "targetMedianPrice": 3.0, "recommendationMean": 2.8, "recommendationKey": "hold", "numberOfAnalystOpinions": 3, "totalCash": 30664000, "totalCashPerShare": 0.426, "ebitda": -91802000, "totalDebt": 18119000, "quickRatio": 1.729, "currentRatio": 2.011, "debtToEquity": 1988.913, "returnOnAssets": -0.88579005, "returnOnEquity": -2.40484, "freeCashflow": -49063376, "operatingCashflow": -80996000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IOBT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "IO Biotech, Inc.", "longName": "IO Biotech, Inc.", "fiftyTwoWeekLowChange": 0.23939997, "fiftyTwoWeekLowChangePercent": 0.74117637, "fiftyTwoWeekRange": "0.323 - 2.79", "fiftyTwoWeekHighChange": -2.2276, "fiftyTwoWeekHighChangePercent": -0.798423, "fiftyTwoWeekChangePercent": -34.99421, "earningsTimestampStart": 1747224300, "earningsTimestampEnd": 1747224300, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.34, "epsForward": -0.36, "epsCurrentYear": -0.88, "priceEpsCurrentYear": -0.6390909, "fiftyDayAverageChange": -0.18950003, "fiftyDayAverageChangePercent": -0.25202823, "twoHundredDayAverageChange": -0.626495, "twoHundredDayAverageChangePercent": -0.5269557, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-05", "averageAnalystRating": "2.8 - Hold", "cryptoTradeable": false, "exchange": "NMS", "messageBoardId": "finmb_1685354464", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1768006248, "regularMarketTime": 1767992401, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1636119000000, "postMarketChangePercent": 6.4900494, "postMarketPrice": 0.5989, "postMarketChange": 0.036500037, "regularMarketChange": 0.00139999, "regularMarketDayRange": "0.56 - 0.59", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2464878, "regularMarketChangePercent": 0.249553, "regularMarketPrice": 0.5624, "marketState": "CLOSED", "displayName": "IO Biotech", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]